Halper Sadeh LLC is investigating whether shareholders of Element Solutions Inc (ESI), Crinetics Pharmaceuticals (CRNX), and Solstice Advanced Materials (SOLS) are receiving fair treatment in their respective sale and merger transactions. The firm highlights concerns that insiders might gain financial benefits not available to ordinary shareholders and that deal terms could restrict better competing offers. Shareholders are encouraged to contact Halper Sadeh LLC for free legal advice and potential claims for increased compensation or disclosures. This investigation could affect the final terms and shareholder rights in these deals.
Advance Auto Parts saw its price target cut from $62 to $43 by Truist after reporting Q2 2026 results with a 0.5% sales decline and weaker-than-expected DIY segment sales. Although adjusted EPS beat estimates at $1.03, this was boosted by a $0.31 tar...
BMO Capital initiated an "Outperform" rating on D-Wave Quantum despite flat Q2 revenues and widening losses, signaling confidence in the company's growth potential. The firm's first-half bookings surged 1,120%, showing strong but volatile demand in q...
QNB Corp. has moved its stock listing from the OTC exchange to the Nasdaq Capital Market and completed a public offering raising approximately $48.3 million by selling 1.23 million shares, including an overallotment option. The funds will be used for...
OSI Systems reported Q4 earnings per share of $3.78, slightly above the $3.77 expected, but revenue fell short at $484.06 million due to geopolitical conflicts. Despite revenue challenges, the company achieved record operating cash flow and secured a...
Several major companies and leveraged ETFs faced significant losses due to market downturns linked to company-specific financing actions and the volatility of underlying stocks. Leveraged ETFs tied to Moderna's stock, such as the Daily Target 2X Long...
